Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.
Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.
复制标题
DOI:
10.3390/ph14050472
复制
发表时间:
2021-05-17
期刊:
影响因子:
--
通讯作者:
Norris RA
中科院分区:
文献类型:
--
作者:
Beck TC;Beck KR;Morningstar J;Benjamin MM;Norris RA
Roughly 2.8% of annual hospitalizations are a result of adverse drug interactions in the United States, representing more than 245,000 hospitalizations. Drug–drug interactions commonly arise from major cytochrome P450 (CYP) inhibition. Various approaches are routinely employed in order to reduce the incidence of adverse interactions, such as altering drug dosing schemes and/or minimizing the number of drugs prescribed; however, often, a reduction in the number of medications cannot be achieved without impacting therapeutic outcomes. Nearly 80% of drugs fail in development due to pharmacokinetic issues, outlining the importance of examining cytochrome interactions during preclinical drug design. In this review, we examined the physiochemical and structural properties of small molecule inhibitors of CYPs 3A4, 2D6, 2C19, 2C9, and 1A2. Although CYP inhibitors tend to have distinct physiochemical properties and structural features, these descriptors alone are insufficient to predict major cytochrome inhibition probability and affinity. Machine learning based in silico approaches may be employed as a more robust and accurate way of predicting CYP inhibition. These various approaches are highlighted in the review.
登录
查看更多内容
影响因子:
14.9
作者:
Banerjee, Priyanka;Dunkel, Mathias;Preissner, Robert
通讯作者:
Preissner, Robert
影响因子:
8.6
作者:
Banerjee P;Siramshetty VB;Drwal MN;Preissner R
通讯作者:
Preissner R
影响因子:
4.6
作者:
Daina A;Michielin O;Zoete V
通讯作者:
Zoete V
影响因子:
7.3
作者:
Halgren, TA;Murphy, RB;Banks, JL
通讯作者:
Banks, JL
影响因子:
29.4
作者:
Fontana, RJ;Lown, KS;Watkins, PB
通讯作者:
Watkins, PB